SB 326 expands the authority of physician assistants (PAs) in Maryland by allowing them to perform specific healthcare actions currently restricted to physicians. The bill directly affects PAs, patients requiring guardianship, inmates needing infirmary care, and mental health facilities by adding PAs to certification requirements for treatment incapacity (Section 5-606), guardianship petitions (Section 13-705), and inmate infirmary admissions (Section 9-601.1). It also requires the Maryland Department of Health to cover PA examinations for emergency evaluations and adds PAs to the Statewide Advisory Commission on Immunization. These changes aim to align PA practice with other licensed healthcare professionals in defined clinical scenarios.
HB 377 expands the scope of practice for physician assistants (PAs) in Maryland by adding them to specific healthcare roles that previously required physicians or other practitioners. The bill allows PAs to certify incapacity for treatment decisions, participate in guardianship petitions for disabled persons, and order infirmary care for pregnant inmates - previously limited to physicians or nurse practitioners. It also requires the Maryland Department of Health to cover PA examinations for emergency evaluees and adds PAs to the Statewide Advisory Commission on Immunization. These changes aim to create parity by treating PAs as equivalent to other licensed healthcare providers in key clinical and administrative processes.
SB 336 extends the deadline for the existing Task Force on Responsible Use of Natural Psychedelic Substances, established by 2024 law, to continue its work studying natural psychedelic substances like psilocybin and mescaline (excluding peyote). The task force, composed of state officials, experts, and community representatives, will study current laws, scientific data on benefits and risks, and barriers to access, then make recommendations for a state access program and legal changes. This extension allows the task force to finalize its report on creating equitable access to these substances and transitioning away from criminal penalties for nonviolent uses. The bill does not change current laws but prolongs the study period to inform future policy decisions.
SB 910 requires Maryland health insurers to reimburse patients for services provided by graduate-level clinical interns in counseling, social work, and psychology, under specific conditions. This affects insured individuals who receive these services and insurers who must cover them. Key conditions include services being provided at outpatient facilities, interns being enrolled in accredited graduate programs, working under direct supervision of a licensed professional, and billed by the supervising provider. The bill amends existing insurance codes (Sections 15-704, 15-707, and 15-714) to add these reimbursement requirements for each profession’s interns.
SB 493 prohibits nursing facilities in Maryland from involuntarily discharging or transferring residents except for specific reasons like the resident's welfare, health improvement, or facility closure. It requires facilities to provide residents with a clear written notice at least 10 days before any involuntary discharge or transfer, detailing the reason, new location, and contact information for hearings and legal assistance. The bill also bans sending residents to temporary housing (like hotels) without confirmation from the receiving facility and prevents facilities from discharging Medicaid-eligible residents solely because they qualify for Medicaid. These changes aim to protect vulnerable residents by ensuring proper notice, preventing unfair treatment, and requiring confirmation before transfers.
SB 562 allows pharmacists in Maryland to treat opioid use disorders using medication therapy under specific conditions. It repeals a requirement that prescribers (like doctors) must submit agreements to their health board and instead authorizes pharmacists to enter into prescriber-pharmacist agreements if they meet qualifications such as holding a Doctor of Pharmacy degree, completing required training, and registering with federal agencies. The law mandates that any treatment protocol requires pharmacists to check the Prescription Drug Monitoring Program before starting or changing medication. This change aims to expand access to medication-based treatment for opioid use disorders by enabling pharmacists to provide care in pharmacy settings.
SB 24 revises Maryland's Public Access Automated External Defibrillator (AED) Program to improve oversight and accessibility. It requires most organizations using public AEDs to appoint an AED coordinator responsible for maintenance, reporting, and emergency notification, while exempting law enforcement agencies from needing certificates for AEDs in patrol vehicles. The bill also repeals outdated requirements for regional AED committees and clarifies that grocery stores and restaurants are not subject to certain AED registration rules. These changes aim to streamline compliance for entities managing public AEDs, including schools, businesses, and public facilities.
SB 14 adjusts when health coverage becomes effective for small businesses using Maryland's SHOP Exchange during specific special enrollment periods. It allows SHOP Exchanges to set coverage start dates based on when plan selections are received: the first day of the following month if received by the 15th, or the second month if received after the 15th. This applies to enrollments triggered by court-ordered dependents (like child support), death of an employee or dependent, or divorce/legal separation. The bill directly affects small employers and their employees/dependents who qualify for these special enrollment scenarios under Maryland's SHOP program. It takes effect October 1, 2026.
SB 139 amends Maryland law to strengthen oversight of third-party administrators (TPAs) who manage insurance claims for employers or insurers. It expands grounds for the Insurance Commissioner to deny, suspend, or revoke a TPA’s registration (including violations of insurance laws or regulations) and updates civil penalty rules. The bill sets a maximum $10,000 penalty per violation for TPA misconduct, with daily penalties up to $1,000 for ongoing violations. Penalties are determined based on factors like violation severity, the TPA’s history, and harm to policyholders, ensuring enforcement considers context and impact.
SB 134 requires Maryland insurance carriers to issue Medicare supplement policies (Medigap) to specific eligible individuals without denying coverage or charging higher premiums based on health status. It directly affects: (1) people transitioning from Maryland Medicaid to Medicare Part B, (2) individuals who became Medicare-eligible before January 2020, and (3) disabled people under 65 who qualify for Medicare. Key provisions mandate that carriers must sell these policies during defined 63-day enrollment periods following Medicaid disenrollment or qualifying events, and prohibit health-based pricing or denial for plans A and D. The law also requires carriers to offer comparable or lower-benefit plans during birthday renewals starting July 2026.
